ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
4 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: American Society of Transplantation Basic Science Fellowship Grant
Applications must be submitted by Monday, September 15, 2014. The funding of any grant and total number of grants awarded by the AST is dependent on budgetary constraints in a given year.
The AST Basic Science Fellowship Grants are intended to support work in transplantation biology ranging broadly from pertinent basic immunology to animal studies. All types of organ, tissue, and cell transplants will be considered. The project should provide a strong training vehicle for the applicant, in keeping with the overall mission of the AST Fellowship Grants.
2015 Basic Science Research Priorities
The AST has identified the following research priorities for 2015, and encourages investigators working within these areas to apply for funding by the AST:
Develop and validate biomarkers of graft dysfunction and immune activation
Validate animal modeling as relevant to current clinical challenges (donor injury, autoimmunuity, infectious disease, immunological memory) that validate specific mechanisms or therapies
Identify and study novel immune modifiers (i.e. cellular transplants including stem cells, new drugs and biologicas)
Pursue systems biology approaches to study the impact of therapeutics on molecular pathways that reveal new mechanistic insights (note: purely descriptive profiling and mapping of molecular pathways by any set of technologies is not responsive to this area)
Develop new tools to study and/or visualize the human immune response
This is a one- or two-year $50,000/year grant designed to provide salary support for fellows at an early stage of their research training (see Eligibility Criteria).
The goals of the AST Fellowship Grants are:
To foster training of new young investigators who have the potential to contribute to our understanding of transplant science/immunobiology and/or treatment of transplant recipients.
To foster research that is of high merit.
To encourage high quality applicants who want to develop a career in academic transplantation.
The AST supports a wide range of basic and clinical research topics. Research topics that involve under-represented areas including minorities, women, and pediatrics are strongly encouraged. The AST also encourages applications from women and minority researchers. Under-represented minority investigators are defined as individuals belonging to a particular ethnic or racial group as determined by the NIH. Established AST members are encouraged to bring this funding opportunity to the attention of new faculty members performing transplantation research at their institutions and to support their applications.
Eligibility Criteria for the AST Basic Science Fellowship Grant
Please pay particular attention to the eligibility requirements, as requirements vary for different AST Grants.
The applicant must be sponsored by an active member of the AST. If the sponsor is not a member, he/she must submit a completed membership application by September 15, 2014 (with expectation that membership will be active before the grant review occurs). Membership dues must be paid to date by November 1, 2014; otherwise, the application will not be considered for funding.
The work must be performed at a North American site under the direct mentorship of an AST member.
The applicant must have an MD, DO, PhD, DMV or equivalent graduate degree at the time of the application.
AST Fellowship Grants are meant for individuals who have spent two years or less (at the time of the application) performing research in the area of transplantation since obtaining their last post-doctoral degree (MD, PhD, or equivalent degree). Applicants who have worked in other fields or taken leaves of absences are eligible beyond this two-year period, but this must be directly addressed in the sponsor's letter.
The applicant must be either: a) a US, Canadian or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the US, Canada, or Mexico with a valid visa during the training period; or c) a foreign national admitted lawfully for residence in the US, Canada, or Mexico during the training period. Funding will not be released until visa status is confirmed.
Throughout the period of the grant, the applicant must be at a "fellowship training" level and may not hold an independent faculty level position or a salaried senior staff position (or equivalent). The AST defines an independent faculty level position as: a) Assistant Professor or equivalent; or b) Regardless of title, institutional support that includes independent lab space and/or start-up funds to allow independent research. The applicant does not need to have actually started their fellowship at the time of application.
The Fellowship Grant is intended to support or supplement salary during the period of research training.
Residual funds can be used for supplies. Funds cannot be used for indirect costs or institutional overhead.
Fellows who have other individual fellowships or grants awarded in their name that support their salary, are not eligible.
The sponsor must guarantee 75% protected time adequate for project completion.
International Council for Laboratory Animal Science-Americas Regional Committee 2014 Travel Fellowship Awards
AALAS meeting – October 19-23, San Antonio, Texas
Deadline for Applications: April 30, 2014
The Americas Regional Committee (ARC) of the International Council for Laboratory Animal Science (ICLAS) announces three Travel Fellowship Awards sponsored by PMI Nutrition International, LLC-LabDiet®, Charles River’s Commitment to Humane Animal Research Through Excellence and Responsibility (CHARTER) Program, and Lab Products, Inc. One award is available to an individual from a member country of the Central American, Caribbean and Mexican Laboratory Animal Science Association (ACCMAL). These are Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Trinidad and Tobago, El Salvador and Honduras. One award is available to an individual from member countries of the Federation of South American Societies and Associations of Laboratory Animal Science Specialists (FESSACAL). These are Argentina, Brazil, Chile, Colombia, Ecuador, Uruguay, and Venezuela. One award will go to the best remaining candidate from all applicants, regardless of his or her country. Each award will sponsor an individual to travel to and participate in the national meeting of the American Association for Laboratory Animal Science (AALAS) to be held on October 19-23, 2014, in San Antonio, Texas, USA.
The AALAS meeting is the largest laboratory animal science meeting in the world. It includes seminars, workshops, special topic lectures, platform sessions, and poster sessions on laboratory animal diseases, biology, experimental techniques, and animal models. The learning resources / technology center includes a variety of videos and computer based programs. Each year there is an extensive commercial exhibit which contains the latest in equipment and ancillary items for the care and use of laboratory animals.
The recipient should be a biomedical scientist, facility manager or veterinarian involved with experimental animals who is a member of his or her local or regional laboratory animal science organization. The individual should be a person with the potential to make significant contributions to the teaching, research, or organizational aspects of laboratory animal science in his or her country. Preference is given to individuals who otherwise would not have funding for international travel to a scientific meeting of this kind.
Each award consists of a monetary award (up to a maximum of $2,000) to be used for costs of air travel, housing, and meeting registration associated with the annual AALAS meeting. In addition, a $500 honorarium will be provided for each recipient to cover costs of meals, local travel, incidentals and any other expenses. The awards will be presented at the 2014 AALAS meeting in San Antonio, Texas, USA.
Nominations or applications should be written in English and consist of:
A cover letter, which should include the candidate’s career goals and a statement with detailed information on the reasons why the candidate is interested in attending the AALAS Annual Meeting. This statement should indicate what he/she is hoping to gain, how he/she would use the knowledge and experience to be acquired, how and with whom that knowledge would be shared, and what benefits will be derived.
A curriculum vitae, maximum of 5 pages in length, with emphasis on laboratory animal science training and experience.
Proof of proficiency in the English language.
A letter of recommendation from the employer.
At least one letter of recommendation from an individual familiar with the qualifications and professional interests and activities of the candidate.
A letter from the applicant’s local or regional association assuring their current membership.
Complete nominations or applications should be submitted by mail or E-mail to:
Dr. Cynthia Pekow
Veterans Affairs Puget Sound Health Care System, (151)
1660 South Columbian Way, Seattle, Washington, USA 98108
Deadline for submission of applications is April 30, 2014. The decision of the committee will be communicated before May 30, 2014.
Scleroderma Foundation Research Grant Funding Program
The grant application deadline is 5 p.m. Eastern Sept. 15 each year. (Note: If the grant deadline falls on a weekend, the following Monday will be the deadline.)
Appropriate Areas of Research and Criteria
Appropriate research areas may include but are not limited to the following as they relate to scleroderma:
Studies of animal models.
Mechanisms of end organ damage.
Endothelial cell biology.
Models and markers of gender and genetic factors.
Stem cell biology.
Health services research (e.g. quality of life, health care delivery.)
Study of clinical manifestation.
Michael J. Fox Foundation for Parkinson's Research Target Validation Program
Fall 2014 Review Cycle
Informational Conference Call*: March 26, 2014 at 12pm US ET
Pre-proposals Due: May 28, 2014 – 6pm US ET
Full Proposal Invitations: June 18, 2014
Full Proposals Due (by invite only): August 6, 2014 – 6pm US ET
Anticipated Award Announcement: October 2014
Anticipated Funding: November 2014
*MJFF will hold a 45-minute conference call on the dates and times listed above to clarify and explain the goals of this funding initiative and answer applicant questions. To participate in the call and receive call-in details, please RSVP via email to email@example.com.
The Target Validation program supports work to determine whether manipulation of a defined biological target provides a disease-relevant beneficial outcome in a whole animal, mammalian model of PD. MJFF does not have any pre-conceived preferences for particular targets submitted to the Target Validation program. However, we recommend applicants consider the following:
The target should be clearly defined, such as:
A specific gene
A structural/functional feature of a protein (e.g., its enzymatic activity, protein conformation or ability to interact with other proteins)
Proposals seeking to manipulate global pathways without a clear target are not encouraged
Applicants may propose a variety of methods to manipulate a target, including but not limited to:
Use of pharmacological tools
Supporting data/explanation of the proposed pharmacological tool must be addressed in the body of the proposal.
Parameters that should be discussed include:
Selectivity for the target of interest
Pharmacokinetic/Pharmacodynamic measures that have been/will be assessed
Measures of target engagement
Use of biologic strategies such as:
Viral vector-mediated gene delivery, etc.
In Vivo Models
Applicants may also propose use of models appropriate for the target proposed including:
Previously established genetically engineered animal models including:
Knockout models where the target/gene of interest is deleted
Transgenic models whereby the target/gene of interest is over-expressed
Investigators should proposed to examine PD-relevant features or sensitivity to PD-associated factors during the course of their studies
Proposals may include intermediate tests using in vitro, ex vivo and/or model organisms (e.g., Drosophila, C. elegans) to optimize the ideal target manipulation strategy
These proposals must ultimately include within the grant funding period an evaluation of the target manipulation in a whole-animal mammalian model of PD
Note: The following types of proposals are not appropriate for the Target Validation program:
Proposals focused on new target identification and proposals testing cellular transplantation approaches.
Proposals seeking to generate new genetic (knockin, knockout, transgenic) models
Investigators seeking guidance to develop new models around their target are encouraged to contact firstname.lastname@example.org
Applicants seeking support for therapeutic development should submit to the Therapeutic Pipeline Program or contact MJFF research staff for guidance.
MJFF will commit up to $10 million to the Edmond J. Safra Core Programs for PD Research with the intention to support multiple awards. The Target Validation program supports two-year grants up to $250,000 total costs inclusive of both direct and indirect costs. The total annual direct costs cannot exceed $100,000. No more than 25% (Academic institutions) or 10% (for-profit organizations) of the direct costs may go to indirect costs.
Applications may be submitted by:
U.S. and non-U.S. biotechnology/pharmaceutical companies or other for-profit entities, either publicly or privately held,
U.S. and non-U.S. entities, public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.
Post-doctoral fellows are NOT eligible to apply as Principal Investigators to the Target Validation program.